Zdrowie i gospodarka · 20/11/2013

FDA Announces Draft Guidance on Product Name Placement in Advertising and Labeling

The Food and Drug Administration (FDA) has released a draft guidance document outlining the requirements for product name placement, size, and prominence in advertising and promotional labeling for prescription human drugs, biological drugs, and prescription animal drugs, which is set to replace the existing guidance issued on January 25, 2012.